Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells

Human Molecular Genetics

Volumn 11, Issue 18, 2002, Pages 2091-2102

  Tao, Qian ^a   Huang, He ^a   Geiman, Theresa M ^b   Lim, Chai Yen ^a   Fu, Li ^a   Qiu, Guo Hua ^a   Robertson, Keith D ^b  

^a Johns Hopkins Singapore   (Singapore)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; AUTOSOME; CANCER; CENTROMERE; CHROMOSOME 1; CHROMOSOME 6; CHROMOSOME ABERRATION; CHROMOSOME CONDENSATION; CHROMOSOME PAIRING; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; EPSTEIN BARR VIRUS; FACE MALFORMATION; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; ICF SYNDROME; IMMUNE DEFICIENCY; MALE; MULTIGENE FAMILY; PRIORITY JOURNAL; RECESSIVE INHERITANCE; TESTIS; X CHROMOSOME;

HUMAN HERPESVIRUS 4;

EID: 0036712913     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.18.2091     Document Type: Article

References (65)

1. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development
2. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene
3. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome
4. The human DNA methyltransferases (DNMTs) 1, 3a, and 3b: Coordinate mRNA expression in normal tissues and overexpression in tumors
5. Cloning, expression and chromosome locations of the human DNMT3 gene family
6. Localization of the ICF syndrome to chromosome 20 by homozygosity mapping
7. DNA methylation, methyltransferases, and cancer
8. ICF syndrome: A new case and review of the literature
9. Variability of clinical and immunological phenotype in immunodeficiency-centromeric instability-facial anamolies syndrome
10. Hypersensitivity to radiation-induced non-apoptotic and apoptotic death in cell lines from patients with the ICF chromosome instability syndrome
11. DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphomagenesis genes
12. DNA hypomethylation and unusual chromosome instability in cell lines from ICF patients
13. An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome
14. Chromosomal localization of human satellites 2 and 3 by FISH method using oligonucleotides as probes
15. Satellite 2 methylation patterns in normal and ICF syndrome cells and association of hypomethylation with advanced replication
16. Whole-genome methylation scan in ICF syndrome: Hypomethylation of non-satellite DNA repeats D4Z4 and NBL2
17. DNA, FISH and complementation studies in ICF syndrome: DNA hypomethylation of repetitive and single copy loci and evidence for a trans acting factor
18. Escape from gene silencing in ICF syndrome: Evidence for advanced replication time as a major determinant
19. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands
20. Epstein-Barr virus
21. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes
22. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state
23. Conservation and progressive methylation of Epstein-Barr viral DNA sequences in transformed cells
24. The role of DNA methylation in modulating Epstein-Barr virus gene expression
25. Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation
26. Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B-cell lymproliferative disease: Application of PCR-based analysis
27. Abnormal methylation pattern in constitutive and facultative (X inactive chromosome) heterochromatin of ICF patients
28. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter
29. Murine de novo methyltransferase Dnmt3a demonstrates strand assymetry and site preference in the methylation of DNA in vitro
30. Preferential methylation of unmethylated DNA by mammalian de novo DNA methyltransferase Dnmt3a
31. Variable immunodeficiency with abnormal condensation of the heterochromatin of chromosomes 1, 9, and 16
32. Methylation-specific PCR: A novel assay for methylation status of CpG islands
33. Synthesis of hypomethylated Epstein-Barr viral DNA is stimulated by dimethylsulfoxide treatment of lymphoblastoid cells
34. A fraction of Epstein-Barr virus virion DNA is methylated in and around the EcoRI-J fragment
35. Cellular and viral DNA hypomethylation associated with induction of Epstein-Barr virus lyric cycle
36. Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection
37. The EBV immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein
38. Epstein-Barr virus bisistronic mRNAs generated by facultative splicing code for two transcriptional transactivators
39. The Zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions
40. Pathways of activation of the Epstein-Barr virus productive cycle
41. Different activation of Epstein-Barr virus immediate-early and early genes in Burkitt lymphoma cells and lymphoblastoid cell lines
42. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism
43. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease
44. Methylation of the Epstein-Barr virus genome in normal lymphocytes
45. Undermethylation of Alu sequences in ICF syndrome: Molecular and in situ analysis
46. New paths in human cancer serology
47. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53
48. Hypermethylation-associated inactivation of p14 (ARF) is independent of p16(INK4a) methylation and p53 mutational status
49. Identification of a meiosis-specific protein as a member of the cancer/testis antigens
50. Purification of CpG islands using a methylated DNA binding column
51. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
52. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases
53. Enzymatic properties of de novo-type mouse DNA (cytosine-5) methyltransferases
54. Epigenetic reprogramming in mammalian development
55. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines
56. De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines
57. Stability of patch methylation and its impact in regions of transcriptional initiation and elongation
58. Evidence that protein binding specifies sites of DNA demethylation
59. In vivo activity of murine de novo methyltransferases, Dnmt3a and Dnmt3b
60. Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines
61. CpG islands in vertebrate genomes
62. The DNA (cytosine-5) methyltransferases
63. Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: Molecular analysis of primary tumor tissue
64. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
65. DNMT1 forms a complex with Rb, E2F1, and HDAC1 and represses transcription from E2F-responsive promoters